Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06478589 · ClinicalTrials.gov registry record · Phase 2
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors
A Phase 2 study of Breast Cancer Survivorship, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT06478589: Recruiting Phase 2 study of Breast Cancer Survivorship, sponsored by The University of Texas Health Science Center, Houston.
NCT06478589 is a Phase 2 study of Breast Cancer Survivorship that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 120 participants, above the 90-participant average among 3 other Breast Cancer Survivorship trials with a reported enrollment target (33% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06478589, a Phase 2 study of Breast Cancer Survivorship, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iterative process in which patients and their physicians help to refine and modify the intervention. A second objective is to evaluate the feasibility and effectiveness of the adapted PPC framework in breast cancer survivorship for older adults.
Primary Outcome
The treatment burden questionnaire (TBQ) measures perceptions of burden of overall care (for example, medication taking, self monitoring, visits to the provider, tests, tasks to access and coordinate care). Total score ranges from 0 to 150, and a higher score indicates greater perceived burden.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL Adapted Patient Priorities Care (PPC) approach
Study Locations (3)
Texas
- UT Physicians Center for Healthy Aging Bellaire - Bellaire
- UT Physicians Family Medicine Bayshore - Houston
- Memorial Hermann Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-01-02 |
| Est. Completion | 2027-06-01 |
| Phase | Phase 2 |
What NCT06478589 shows while recruiting
NCT06478589 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 90-participant average among 3 other Breast Cancer Survivorship trials with a reported enrollment target (33% higher).
The record links to 1 condition, with Breast Cancer Survivorship appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06478589 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06478589 about?
NCT06478589 is a clinical study titled "Patient Priorities for Survivorship Care in Older Breast Cancer Survivors". The objective of this study is to adapt the Patient Priorities Care (PPC) framework to breast cancer survivorship via a user-centered approach, through an iterative process in which patients and their physicians help to refine and modify the intervention. A second objective is to evaluate the feasib...
What is the current status of trial NCT06478589?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2025-01-02. Estimated completion is 2027-06-01.
What conditions does trial NCT06478589 study?
This clinical trial studies the following conditions: Breast Cancer Survivorship.
What interventions are being tested in trial NCT06478589?
The interventions under investigation include: Usual Care (OTHER), Adapted Patient Priorities Care (PPC) approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT06478589?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06478589 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivorship
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI